These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 32885357)

  • 21. Lyophilization cycle design for highly concentrated protein formulations supported by micro freeze-dryer and heat flux sensor.
    Carfagna M; Rosa M; Hawe A; Frieß W
    Int J Pharm; 2023 Aug; 643():123285. PubMed ID: 37532010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Best Practices and Guidelines (2022) for Scale-Up and Tech Transfer in Freeze-Drying Based on Case Studies. Part 1: Challenges during Scale Up and Transfer.
    Tchessalov S; Shalaev E; Bhatnagar B; Nail S; Alexeenko A; Jameel F; Srinivasan J; Dekner M; Sahni E; Schneid S; Kazarin P; McGarvey O; Van Meervenne B; Kshirsagar V; Pande P; Philipp J; Sacha G; Wu K; Azzarella J; Shivkumar G; Bhatt S
    AAPS PharmSciTech; 2022 Nov; 24(1):11. PubMed ID: 36451057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein purification process engineering. Freeze drying: A practical overview.
    Gatlin LA; Nail SL
    Bioprocess Technol; 1994; 18():317-67. PubMed ID: 7764173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Freeze drying--principles and practice for successful scale-up to manufacturing.
    Tsinontides SC; Rajniak P; Pham D; Hunke WA; Placek J; Reynolds SD
    Int J Pharm; 2004 Aug; 280(1-2):1-16. PubMed ID: 15265542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimization of Primary Drying in Lyophilization During Early-Phase Drug Development Using a Definitive Screening Design With Formulation and Process Factors.
    Goldman JM; More HT; Yee O; Borgeson E; Remy B; Rowe J; Sadineni V
    J Pharm Sci; 2018 Oct; 107(10):2592-2600. PubMed ID: 29890172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Software Tool for Lyophilization Primary Drying Process Development and Scale-up Including Process Heterogeneity, I: Laboratory-Scale Model Testing.
    Bogner R; Gong E; Kessler W; Hinds M; Manchanda A; Yoon S; Liu H; Marx R; Zhao J; Sharma P; Bhambhani A; Stanbro J; Alexeenko A; Kazarin P
    AAPS PharmSciTech; 2021 Nov; 22(8):274. PubMed ID: 34773199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Freezing on Lyophilization Process Performance and Drug Product Cake Appearance.
    Esfandiary R; Gattu SK; Stewart JM; Patel SM
    J Pharm Sci; 2016 Apr; 105(4):1427-33. PubMed ID: 27019959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of an efficient single-step freeze-drying cycle for protein formulations.
    Chang BS; Fischer NL
    Pharm Res; 1995 Jun; 12(6):831-7. PubMed ID: 7667186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of a temperature ramp approach (TRA) to design an optimum and robust freeze-drying process for pharmaceutical formulations.
    Assegehegn G; Brito-de la Fuente E; Franco JM; Gallegos C
    Int J Pharm; 2020 Mar; 578():119116. PubMed ID: 32027958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lyophilized Drug Product Cake Appearance: What Is Acceptable?
    Patel SM; Nail SL; Pikal MJ; Geidobler R; Winter G; Hawe A; Davagnino J; Rambhatla Gupta S
    J Pharm Sci; 2017 Jul; 106(7):1706-1721. PubMed ID: 28341598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Storage and Lyophilization of Pure Proteins.
    Ó'Fágáin C; Colliton K
    Methods Mol Biol; 2023; 2699():421-475. PubMed ID: 37647008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preventing Cross-Contamination during Lyophilization: GMP and Occupational Cleaning Requirements for Nonproduct and Indirect Product-Contact Parts.
    Denk R; Flückiger A; Kisaka H; Krause S; Maeck R; Restetzki L; Schreiner A; Schulze R
    PDA J Pharm Sci Technol; 2019; 73(5):487-495. PubMed ID: 31420508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The application of dual-electrode through vial impedance spectroscopy for the determination of ice interface temperatures, primary drying rate and vial heat transfer coefficient in lyophilization process development.
    Smith G; Jeeraruangrattana Y; Ermolina I
    Eur J Pharm Biopharm; 2018 Sep; 130():224-235. PubMed ID: 29940225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Process optimization and transfer of freeze-drying in nested vial systems.
    Ehlers S; Schroeder R; Friess W
    Eur J Pharm Biopharm; 2021 Feb; 159():143-150. PubMed ID: 33429009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Freezing process influences cake appearance of a lyophilized amorphous protein formulation with low solid content and high fill configuration.
    Lu X; Kulkarni SS; Dong H; Tang Y; Yi L; Gupta S
    Int J Pharm; 2023 Apr; 636():122803. PubMed ID: 36894041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rational design of heat stable lyophilized rotavirus vaccine formulations.
    Madan M; Sikriwal D; Sharma G; Shukla N; Mandyal AK; Kale S; Gill D
    Hum Vaccin Immunother; 2018; 14(9):2132-2141. PubMed ID: 29953317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "Product on Stopper" in a Lyophilized Drug Product: Cosmetic Defect or a Product Quality Concern?
    Mehta SB; Roy S; Yang HC
    J Pharm Sci; 2018 Jun; 107(6):1736-1740. PubMed ID: 29432763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A study of the impact of freezing on the lyophilization of a concentrated formulation with a high fill depth.
    Liu J; Viverette T; Virgin M; Anderson M; Paresh D
    Pharm Dev Technol; 2005; 10(2):261-72. PubMed ID: 15926675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The freezing step in lyophilization: physico-chemical fundamentals, freezing methods and consequences on process performance and quality attributes of biopharmaceuticals.
    Kasper JC; Friess W
    Eur J Pharm Biopharm; 2011 Jun; 78(2):248-63. PubMed ID: 21426937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling of heat and mass transfer processes for the gap-lyophilization system using the mannitol-trehalose-NaCl formulation.
    Kuu WY; Doty MJ; Nisipeanu E; Rebbeck CL; Cho YK; Smit MH
    J Pharm Sci; 2014 Sep; 103(9):2784-2796. PubMed ID: 24648334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.